Biomarker-Guided Immunosuppression Found Safe in Kidney Transplant Patients, Major European Study Shows
A groundbreaking European clinical trial has shown that using a common, harmless virus as a biomarker to guide immunosuppressive treatment after kidney transplantation is both safe and effective, paving the way for more personalized transplant care.












